Bright Minds Biosciences Inc. DRUG.CN Stock
Bright Minds Biosciences Inc. Price Chart
Bright Minds Biosciences Inc. DRUG.CN Financial and Trading Overview
| Bright Minds Biosciences Inc. stock price | 1.65 CAD |
| Previous Close | 0.75 CAD |
| Open | 0 CAD |
| Bid | 0.75 CAD x N/A |
| Ask | 0.8 CAD x N/A |
| Day's Range | 0 - 0 CAD |
| 52 Week Range | 0 - 6.07 CAD |
| Volume | 0 CAD |
| Avg. Volume | 12.58K CAD |
| Market Cap | 14.33M CAD |
| Beta (5Y Monthly) | 1.325032 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.77 CAD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 11.5 CAD |
DRUG.CN Valuation Measures
| Enterprise Value | 4.58M CAD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 1.6033754 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Bright Minds Biosciences Inc. Stock Price History
| Beta (5Y Monthly) | 1.325032 |
| 52-Week Change | -33.91% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 6.07 CAD |
| 52 Week Low | 0 CAD |
| 50-Day Moving Average | 0.76 CAD |
| 200-Day Moving Average | 1.09 CAD |
DRUG.CN Share Statistics
| Avg. Volume (3 month) | 12.58K CAD |
| Avg. Daily Volume (10-Days) | 3.02K CAD |
| Shares Outstanding | 18.86M |
| Float | 15.88M |
| Short Ratio | 5.09 |
| % Held by Insiders | 23.85% |
| % Held by Institutions | 2.20% |
| Shares Short | 130.67K |
| Short % of Float | 0.91% |
| Short % of Shares Outstanding | 0.68% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | September 30, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | September 30, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -56.51% |
| Return on Equity (ttm) | -101.54% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -10005320 CAD |
| Diluted EPS (ttm) | -0.67 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 9.67M CAD |
| Total Cash Per Share (mrq) | 0.51 CAD |
| Total Debt (mrq) | 108.32K CAD |
| Total Debt/Equity (mrq) | 1.21 CAD |
| Current Ratio (mrq) | 9.827 |
| Book Value Per Share (mrq) | 0.474 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -9166863 CAD |
| Levered Free Cash Flow (ttm) | -5236168 CAD |
Profile of Bright Minds Biosciences Inc.
| Country | Canada |
| State | NY |
| City | New York |
| Address | 19 Vestry Street |
| ZIP | 10013 |
| Phone | 647 407 2515 |
| Website | https://brightmindsbio.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Bright Minds Biosciences Inc., a biotechnology company, develops 5-HT (serotonin) medicines to improve the lives of patients with severe and life-altering diseases. Its portfolio of selective 5-HT receptor agonists includes 5-HT2C, 5-HT2A, and 5-HT2C/A for the treatment of epilepsy, pain, and neuropsychiatry. The company has collaboration with National Institutes of Health for the treatment of epilepsy; University of Texas Medical Branch to treat impulse control disorders, such as binge eating; and Medical College of Wisconsin. Bright Minds Biosciences Inc. was founded in 2017 and is headquartered in New York, New York.
Q&A For Bright Minds Biosciences Inc. Stock
What is a current DRUG.CN stock price?
Bright Minds Biosciences Inc. DRUG.CN stock price today per share is 1.65 CAD.
How to purchase Bright Minds Biosciences Inc. stock?
You can buy DRUG.CN shares on the Canadian Sec exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Bright Minds Biosciences Inc.?
The stock symbol or ticker of Bright Minds Biosciences Inc. is DRUG.CN.
Which industry does the Bright Minds Biosciences Inc. company belong to?
The Bright Minds Biosciences Inc. industry is Biotechnology.
How many shares does Bright Minds Biosciences Inc. have in circulation?
The max supply of Bright Minds Biosciences Inc. shares is 4.46M.
What is Bright Minds Biosciences Inc. Price to Earnings Ratio (PE Ratio)?
Bright Minds Biosciences Inc. PE Ratio is now.
What was Bright Minds Biosciences Inc. earnings per share over the trailing 12 months (TTM)?
Bright Minds Biosciences Inc. EPS is -1.77 CAD over the trailing 12 months.
Which sector does the Bright Minds Biosciences Inc. company belong to?
The Bright Minds Biosciences Inc. sector is Healthcare.